The factsheet has been successfully sent.
Please check your inbox.
Please fill in the form to receive the factsheet directly into your inbox

You have items in your inquiry list.
Inquire now?

13 Apr 2016 [Press release]

Genotype the right thing for better HCV treatment

Hepatitis C is a viral infection that causes inflammation of the liver. For some people, hepatitis C is a short-term illness, but for 70%–85% of people who become infected with Hepatitis C, it becomes a long-term, chronic infection. Chronic Hepatitis C is a serious disease than can result in long-term health problems, even death.

There’re commonly 6 HCV variants (1-6) and genotyping those variants will help determine the correct treatment. Simeprevir is an oral hepatitis C virus protease inhibitor approved for treatment of chronic HCV infection. It’s highly effective for HCV genotype 1. However, patients with HCV 1a Q80K have a significantly low Sustained Virologic Response (SVR).

DiagCor’s GenoFlow HCV array test kit genotypes 1-6, 1a, 1b subtypes and Q80K mutation, which provides more treatment methods for HCV and helps make treatment desicion for HCV. It also detects the presence of rare genotypes through universal probe.

About DiagCor

Headquartered in Hong Kong, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, Diagcor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.

Press Contact

DiagCor Life Science